Fabrizio Fabris

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli et al. · Blood · 2007 · 444 citations

Life Sciences, Genetics, Molecular Genetics +10

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study

Bruno Girolami, Paolo Prandoni, Piero Maria Stefani et al. · Blood · 2003 · 274 citations · Full text

Medicine, Hematology, Internal Medicine +13

The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study

Paolo Prandoni, Sergio Siragusa, Bruno Girolami et al. · Blood · 2005 · 214 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

<i>MYH9</i>-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations

Alessandro Pecci, Catherine Klersy, Paolo Gresele et al. · Human Mutation · 2013 · 200 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history ofMYH9-related disease

Alessandro Pecci, Emanuele Panza, Núria Pujol‐Moix et al. · Human Mutation · 2007 · 185 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16